Advert - Leo Pharma - Case/0349/11/24 and Case/0350/11/24

• Date posted
  15 July 2025
• Sanction
  Advertisement,
• Case number/s
  CASE/0349/11/24 and CASE/0350/11/24 - Complainant v LEO Pharma

For the inclusion of inaccurate and misleading information in the ‘Tinzahelp administration’ app for patients prescribed tinzaparin sodium, and a failure to withdraw such information immediately, LEO Pharma was ruled in breach of the following clauses of the 2024 Code:

Clause 2           - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry

Clause 5.1        - Failing to maintain high standards

Clause 6.1        - Providing misleading information

Clause 26.2      - Providing inaccurate information about a prescription only medicine to the public

The case report is available at www.pmcpa.org.uk.